학술논문
Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome?
Document Type
Original Paper
Author
Source
Leukemia. 37(12):2517-2519
Subject
Language
English
ISSN
0887-6924
1476-5551
1476-5551